OGN Organon & Co

$7.21

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Organon & Co

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.

Website: https://www.organon.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1821825
Address
30 HUDSON STREET, FL 33, JERSEY CITY, NJ, US
Valuation
Market Cap
$2.87B
P/E Ratio
3.34
PEG Ratio
nan
Price to Book
6.08
Performance
EPS
$3.33
Dividend Yield
10.10%
Profit Margin
13.50%
ROE
43.00%
Technicals
50D MA
$14.43
200D MA
$17.16
52W High
$22.29
52W Low
$10.75
Fundamentals
Shares Outstanding
258M
Target Price
$20.00
Beta
0.69

OGN EPS Estimates vs Actual

● Estimated
● Actual

OGN News & Sentiment

Nov 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Organon & Co. ( OGN ) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Nov 14, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Interim Report - January-September 2025
STOCKHOLM - 14 November 2025. Karolinska Development AB ( Nasdaq Stockholm: KDEV ) today publishes its Interim Report January-September 2025. The full report is available on the Company's website.
Nov 11, 2025 • Benzinga NEUTRAL
Organon Analysts Cut Their Forecasts Following Q3 Results - Organon ( NYSE:OGN )
Organon ( NYSE:OGN ) reported better-than-expected earnings for the third quarter on Monday. The company posted third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus estimate of 94 cents.
Nov 10, 2025 • Benzinga NEUTRAL
Organon Cuts 2025 Sales Outlook Despite Earnings Beat - Organon ( NYSE:OGN )
Organon ( NYSE:OGN ) reported third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus estimate of 94 cents. The global healthcare company reported quarterly sales of $1.602 billion, beating the Wall Street estimate of $1.56 billion.
Nov 10, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Organon ( OGN ) Q3 Earnings and Revenues Beat Estimates
Organon (OGN) delivered earnings and revenue surprises of +8.60% and +2.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 27, 2025 • Benzinga NEUTRAL
Organon & Co. ( OGN ) Faces Investor Scrutiny Amid Improper Wholesale Sales Practices, Abrupt CEO Departure -- Hagens Berman - Organon ( NYSE:OGN )
SAN FRANCISCO, Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- On October 27, 2025, investors in Organon & Co. ( NYSE:OGN ) saw the price of their shares plummet $2.10 ( -23% ) after the company announced the findings of its Audit Committee's investigation into improper wholesale sales practices for ...
Sentiment Snapshot

Average Sentiment Score:

0.221
50 articles with scored sentiment

Overall Sentiment:

Bullish

OGN Reported Earnings

Aug 05, 2025
Jun 30, 2025 (Pre market)
0.06 Surprise
  • Reported EPS: $1.00
  • Estimate: $0.94
  • Whisper: —
  • Surprise %: 6.4%
May 01, 2025
Mar 31, 2025 (Pre market)
0.13 Surprise
  • Reported EPS: $1.02
  • Estimate: $0.89
  • Whisper: —
  • Surprise %: 14.6%
Feb 13, 2025
Dec 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $0.90
  • Estimate: $0.87
  • Whisper: —
  • Surprise %: 3.5%
Oct 31, 2024
Sep 30, 2024 (Pre market)
-0.03 Surprise
  • Reported EPS: $0.87
  • Estimate: $0.90
  • Whisper: —
  • Surprise %: -3.3%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $1.12
  • Estimate: $1.08
  • Whisper: —
  • Surprise %: 3.7%
May 02, 2024
Mar 31, 2024 (Pre market)
0.25 Surprise
  • Reported EPS: $1.22
  • Estimate: $0.97
  • Whisper: —
  • Surprise %: 25.8%
Feb 15, 2024
Dec 31, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $0.88
  • Estimate: $0.83
  • Whisper: —
  • Surprise %: 6.0%
Nov 02, 2023
Sep 30, 2023 (Pre market)
-0.19 Surprise
  • Reported EPS: $0.87
  • Estimate: $1.06
  • Whisper: —
  • Surprise %: -17.9%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.3 Surprise
  • Reported EPS: $1.31
  • Estimate: $1.01
  • Whisper: —
  • Surprise %: 29.7%

Financials